News About: Goverment
Debate heating up over reference pricing system
A controversy is mounting over whether the government should implement the new drug-pricing system, known as the "reference pricing system (RPS)," in coming September in order to cut the drug charges, since a number o...
BAI filed corrections during MOHW's audit inspection
In its 2001 audit inspection on the Ministry of Health and Welfare and its affiliated agencies, the Board of Audit and Inspection (BAI) said that a total of 79 cases were discovered for due administrative dispositions...
Implementation of minimum drug pricing system slated for coming September
Drug re-evaluation system will be regularly implemented every three years and the reimbursement calculation criteria for insurance drug prices will be also changed from the existing weighed average pricing calculation...
KFDA to foster Korea's infrastructure for the development of new drugs
The toxicological test data, which will be completed at the end of this year, can be acknowledged regardless of their submission period and their application next year may be allowed, if deemed feasible under review, ...
Reference price system to launch in 2 months.
It is very likely for the new NHI drug pricing system called "Reference Price System" to be enforced after the public hearing in 2 months to come, according to Minister Kim Sung-ho of MOHW in his press interview on Au...
25 items of Pfizer Korea are subject to suspension of manufacturing business
In line with the recent controversy on the mixed packaging of both Cardura(doxazosin mesylate) and Cofrel (benproperine phosphate), 25 items of Pfizer Korea including Norvasc (amlodipine besylate) will subject to the ...
Minimum drug pricing systemdraws varying reactions from domestic pharmaceutical industry
With the tentative one-year implementation of the minimum drug pricing system in favor of the lowest drug prices in the reimbursement calculation of health insurance drug charges, the domestic pharmaceutical industry ...
KFDA under establishment of policy think-tank.
The KFDA's administration seems to be transformed to cope with ever changing circumstances. To this end the KFDA plans to form a think-tank titled "the Pharmaceutical Affairs Administration Development Planning Team" ...
Prescriptions in domestic generic drugs on the rise.
The medical institutions have issued a growing number of prescriptions for more domestic generic drugs instead of expensive foreign branded since the former minister Lee Tae-bok' position change scandal that raised a ...
Arbitration-based non-exclusive license on Glivec eyed
The arbitration-based non-exclusive license (ANEL) on Glivec is now emerging as a hot issue, amid the prolonged showdown on its pricing among the interested parties.
According to the Joint Countermeasure Committee ...
